Literature DB >> 6151355

Persistence of tick-borne encephalitis virus in monkeys. VII. Some features of the immune response.

V V Pogodina, N G Bochkova, L S Levina.   

Abstract

Tick-borne encephalitis (TBE) virus persists in experimentally infected rhesus monkeys in the presence of humoral antibodies. Various dynamics of the humoral response (stable, increasing, decreasing, undulatory titres) have been noted, associated with complete or incomplete set of antibodies. Always present were the virus-neutralizing antibodies, often the complement-fixing antibodies, less frequently precipitating and haemagglutination inhibition (HI) antibodies were found. There was a correlation between the set of antibodies present and the virus-specific antigens expressed; the persisting TBE virus was usually deficient in haemagglutinin synthesis. In cases of asymptomatic infection a more expressed and long-lasting immunity as observed with the persistence of TBE virus in organs of the immune system.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6151355

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  4 in total

1.  Role of CD8+ T cells in control of West Nile virus infection.

Authors:  Bimmi Shrestha; Michael S Diamond
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

2.  A hamster-derived West Nile virus strain is highly attenuated and induces a differential proinflammatory cytokine response in two murine cell lines.

Authors:  Vandana Saxena; Thomas Welte; Xiaoyong Bao; Guorui Xie; Jia Wang; Stephen Higgs; Robert B Tesh; Tian Wang
Journal:  Virus Res       Date:  2012-05-10       Impact factor: 3.303

Review 3.  Immune responses to West Nile virus infection in the central nervous system.

Authors:  Hyelim Cho; Michael S Diamond
Journal:  Viruses       Date:  2012-12-17       Impact factor: 5.048

Review 4.  The role of viral persistence in flavivirus biology.

Authors:  Luwanika Mlera; Wessam Melik; Marshall E Bloom
Journal:  Pathog Dis       Date:  2014-05-12       Impact factor: 3.166

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.